Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of GMDS protein | affects expression | 20106945
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GMDS mRNA | affects cotreatment|increases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GMDS mRNA | decreases expression | 20106945 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GMDS mRNA | decreases expression | 20713471
|
C459604 |
candoxin |
candoxin results in decreased expression of GMDS mRNA | decreases expression | 16309724
|
C014347 |
decitabine |
decitabine results in decreased expression of GMDS mRNA | decreases expression | 19194470
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GMDS mRNA | affects cotreatment|increases expression | 18164116
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of GMDS mRNA | increases expression | 18301758
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GMDS mRNA | decreases expression | 20106945
|
D019772 |
Topotecan |
GMDS protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 11752688 15322242 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.02 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.86 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
11.86 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.86 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
19.03 | 19052882 17620307 16434500 19061943 18056438 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
19.03 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
19.03 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.96 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.96 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.96 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.14 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.14 | 16681979 17173139 18691550 18506893 3581430 10672840 19335982 18210153 19394651 17761372 18665156 16502159 20084675 16878318 19519916 19171122 20432363 17978847 16807293 19052882 11831363 19919837 16779866 3084413 19418558 16935385 20935162 20214788 19822196 20727157 17428255 17138121 20007298 19208518 10737359 20514400 20524982 19701751 18978308 19539802 18971187 18393292 18785209 16328049 21159647 18788625 18056438 16569478 18494052 16288022 16830150 17162532 19107877 16540662 17055752 16698587 20101231 20512989 19383236 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.85 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.85 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.99 | 2727394 17174075 21159647 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.94 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.94 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.36 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.36 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.36 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.90 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.90 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.23 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.23 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 16714409 15322242 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.43 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.44 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.05 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.37 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.37 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.21 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.62 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.77 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.77 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.14 | 16221962 19772884 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.14 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.33 | 17581917 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.22 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.22 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.76 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.16 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.21 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.41 | 18704418 18460780 19387464 17679729 18206229 19010910 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.78 | 18055864 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.93 | 20032147 19638242 18522880 18665156 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.14 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
18.90 | 15890375 2125692 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
18.90 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
18.90 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.90 | 15175105 19073162 19812893 19090486 19254457 20492335 19690152 10737359 18644402 20405173 18648771 16942905 20101389 18978307 21278145 21047994 18977376 21167192 19427195 21071580 12112319 20118626 19294768 19642983 19426721 19256749 19499222 19833225 18754104 20501860 20137499 9163691 12771043 19551842 20452335 2862719 19638242 2422723 20434301 19255062 20583210 19850985 19996281 15885732 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
18.90 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
18.90 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
15.16 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
15.16 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
15.16 | 18282651 19009564 21159647 18253720 17854601 18775883 16842330 19539802 19004024 18544905 17942915 18164116 19126423 16267830 18308698 18079962 19519916 17174075 3124819 18093689 9362446 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
15.16 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.99 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.99 | 20464547 17053015 18816296 20869020 18569708 20064080 20135361 18520028 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.99 | 20512841 20970405 21163286 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.99 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.56 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.27 | 16505122 17785578 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.35 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.49 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.49 | 19157545 18608210 19010910 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.64 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.77 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.77 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.77 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.94 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.51 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.44 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.70 | 19259094 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.57 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.57 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.73 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11399792 11118676 11222880 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.99 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.94 | 17292933 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.62 | 19155313 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.76 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.76 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.46 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.46 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.46 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.80 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.80 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.36 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.36 | 17616700 19087683 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.23 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |